Bloomberg Law
Free Newsletter Sign Up
Login
BROWSE
Bloomberg Law
Welcome
Login
Advanced Search Go
Free Newsletter Sign Up

Sanofi Wins Appeal Ruling Upholding Patent on Jevtana (2)

Aug. 14, 2019, 2:45 PMUpdated: Aug. 14, 2019, 4:43 PM

Sanofi patent on prostate-cancer drug expiring in 2021 was correctly upheld by trial court, U.S. Court of Appeals for the Federal Circuit said Aug. 14 in an opinion posted on its electronic docket.

  • Generic-drug makers including Fresenius, Mylan, Apotex lose bid to invalidate patent covering the cabazitaxel compound and related pharmaceutical compositions
  • Part of the appeal involving a second patent, which expires in 2031, was dismissed after appeals court said there was no longer a dispute over those patent claims
  • NOTE: Sanofi dropped those claims as part of a review of the overall patent at the Patent Trial and Appeal ...